Send mail to Author

Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE : a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______   __   __   __   _     _____     ____     _    _   
 /_   _//  \ \\/ // | || | ||  |  ___||  |  _ \\  | || | || 
   | ||     \ ` //  | '--' ||  | ||__    | |_| || | || | || 
  _| ||      | ||   | .--. ||  | ||__    | .  //  | \\_/ || 
 /__//       |_||   |_|| |_||  |_____||  |_|\_\\   \____//  
 `--`        `-`'   `-`  `-`   `-----`   `-` --`    `---`
 


Back to frontdoor view

OPUS4 Logo